Management of Premature Atherosclerotic Heart Disease

Core Pharmacological Therapy

• The American College of Cardiology recommends high-intensity statin therapy to achieve LDL-C <55 mg/dL, with aspirin 75-162 mg daily, beta-blockers, and ACE inhibitors or ARBs for life, combined with aggressive lifestyle modification 1, 2, 3
• Aspirin 75-162 mg daily must be started immediately and continued indefinitely, unless contraindicated, as this is mandatory for all patients with coronary artery disease 1, 2, 3
• Clopidogrel 75 mg daily serves as an alternative if aspirin is not tolerated or the patient has aspirin allergy 1, 2
• For patients with acute coronary syndrome or recent PCI with stent placement, dual antiplatelet therapy should continue for at least 12 months 1
• High-intensity statin therapy is required immediately to achieve LDL-C <55 mg/dL, even more aggressive than the older <100 mg/dL target 1, 2
• Start dietary therapy simultaneously: limit saturated fat to <7% of calories and cholesterol to <200 mg/day 4, 2
• If LDL-C remains ≥100 mg/dL despite maximum tolerated statin dose, add ezetimibe 1
• For very high-risk patients not reaching goals on statin plus ezetimibe, add a PCSK9 inhibitor 1
• For triglycerides 200-499 mg/dL after LDL goals are met, consider adding fibrate or niacin 4, 2
• Target HDL-C >35 mg/dL and triglycerides <150 mg/dL as secondary goals 4
• Beta-blockers are mandatory in all patients with prior myocardial infarction and must be continued for at least 3 years, but preferably indefinitely 1, 3
• ACE inhibitors should be started immediately and continued indefinitely in all patients with established atherosclerotic cardiovascular disease 1, 2, 3
• ARBs are appropriate alternatives if ACE inhibitors cause intolerable cough or angioedema 1, 3

Blood Pressure Management

• Target blood pressure <140/90 mmHg for most patients with stable cardiovascular disease 1
• A lower target of <130/80 mmHg may be considered in select individuals with previous stroke, TIA, or prior MI 1
• Initiate lifestyle modifications for all patients with BP ≥130/80 mmHg 4, 5
• Critical pitfall: Never lower diastolic blood pressure below 60 mmHg, especially in patients with myocardial ischemia, as this may worsen ischemia 1

Lifestyle Modification

• Complete cessation of all tobacco products is mandatory and non-negotiable 4, 5, 2
• Minimum of 30-60 minutes of moderate to vigorous aerobic activity daily, or at least 3-4 times weekly 4, 5, 2
• Mediterranean diet rich in legumes, dietary fiber, nuts, fruits, vegetables, with high flavonoid intake is strongly recommended 5
• Limit saturated fat to <7% of total calories, cholesterol to <200 mg/day, and trans-fatty acids 4, 6
• Limit sodium intake to <6 g per day 6
• Target BMI 18.5-24.9 kg/m² 4, 1
• Target waist circumference <40 inches in men and <35 inches in women 1

Diabetes Management (if applicable)

• In patients with type 2 diabetes and established atherosclerotic cardiovascular disease, add an SGLT2 inhibitor with proven cardiovascular outcomes benefit 1
• Target HbA1c approximately 7% for most patients 1

Surveillance and Follow-Up

• Regular follow-up visits every 3-6 months initially to reassess risk status, medication adherence, and achievement of cardiovascular risk factor targets 1
• Assess lipid profile 4-12 weeks after initiating or adjusting statin therapy 1
• At every visit, assess tobacco use, dietary adherence, physical activity patterns, weight, and blood pressure 4, 6

Critical Pitfalls to Avoid

• Do not withhold beta-blockers based solely on age—they provide prognostic benefit in coronary artery disease regardless of age 1, 3
• Avoid atenolol—use alternative beta-blockers with proven outcomes benefit (carvedilol, metoprolol succinate, bisoprolol, propranolol) 1
• Do not combine beta-blockers with nondihydropyridine calcium channel blockers (verapamil, diltiazem) unless absolutely necessary due to bradyarrhythmia risk 1
• Avoid nondihydropyridine calcium channel blockers in patients with left ventricular dysfunction 1
• Do not lower diastolic blood pressure below 60 mmHg or systolic blood pressure below 130 mmHg in octogenarians 1
• Nitrates should not be used to improve long-term prognosis after MI—they provide symptomatic relief only 2, 3
• Calcium channel blockers have weaker evidence for benefit compared to beta-blockers and should not be first-line therapy 2, 3